Inactive Instrument

Luminex Corporation

Equities

LMNX

US55027E1029

Advanced Medical Equipment & Technology

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million. CI
Transcript : Cytek Biosciences, Inc., Luminex Corporation - M&A Call
Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million. CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000 CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500 CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 CI
Luminex Corporation Announces Executive Changes CI
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index CI
DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others. CI
Update: Middlesex Water to Replace Luminex in S&P SmallCap 600 -- Shares Jump in Pre-Market Trading MT
Middlesex Water : to Replace Luminex in S&P SmallCap 600 MT
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Biotechnology Index CI
Middlesex Water : S&P Dow Jones Indices Says Middlesex Water Company (MSEX) to Replace Luminex (LMNX) in S&P SmallCap 600 from July 15 MT
Luminex : Gets US Regulatory Approval for Acquisition by DiaSorin MT
Luminex : Quarterly Dividend Unchanged at $0.10 Per Share, Payable July 8 to Stockholders of Record on June 17 MT
Luminex Corporation Declared Cash Dividend for the Second Quarter of 2021, Payable on July 8, 2021 CI
Luminex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37 MT
LUMINEX : BTIG Downgrades Luminex to Neutral From Buy MT
Sector Update: Health Care Stocks Slip as Midday Gains Evaporate MT
Sector Update: Health Care Stocks Drifting Higher This Afternoon MT
Sector Update: Health Care MT
Chart Luminex Corporation
More charts
Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.
More about the company
  1. Stock
  2. Equities
  3. Stock Luminex Corporation - Nasdaq
  4. News Luminex Corporation
  5. Sector Update: Health Care Stocks Drifting Higher This Afternoon